Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate.
about
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patientsA computerized treatment algorithm trial to optimize mineral metabolism in ESRD.Treatment of secondary hyperparathyroidism in kidney disease: what we know and do not know about use of calcimimetics and vitamin D analogs.Long-term prognosis of parathyroid function in chronic dialysis patients after PEIT-a single-centre trial.Efficacy of early treatment with calcimimetics in combination with reduced doses of vitamin d sterols in dialysis patients.A Randomized Trial of Cinacalcet versus Vitamin D Analogs as Monotherapy in Secondary Hyperparathyroidism (PARADIGM)An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjects.Clinical and Practical Use of Calcimimetics in Dialysis Patients With Secondary Hyperparathyroidism.Medical therapy of secondary hyperparathyroidism in chronic kidney disease: old and new drugs.Calcimimetics as an adjuvant treatment for familial hypophosphatemic ricketsNew strategies for the treatment of hyperparathyroidism incorporating calcimimetics.Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift?Long-term cinacalcet HCl treatment improved bone metabolism in Japanese hemodialysis patients with secondary hyperparathyroidism.Therapeutic management of post-kidney transplant hyperparathyroidism.Mineral metabolism and vitamin D in chronic kidney disease--more questions than answers.Cinacalcet and Clinical Outcomes in Dialysis.Long-Term Hypoparathyroidism and Hypophosphatemia in Dialysis PatientsEfficacy of cinacalcet with low-dose vitamin D in incident haemodialysis subjects with secondary hyperparathyroidism.Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients.
P2860
Q24187385-F1347157-A26C-499B-BBBC-BA26C9A1084EQ30421529-BFCC817A-8512-434D-8619-A333670EC1ECQ35026640-36DD7A13-68A8-4D52-AE37-BB8E6A16AA96Q35573606-CB790E47-D771-4065-B582-EA3B97B8FFD7Q35573639-E9305D06-CA86-46B8-B06B-37E846A8021DQ35682192-27FFD1B1-184A-4398-8E62-9DE44BDE05F7Q36173980-D6305002-39C6-4590-8A0A-9738ADD42ABDQ36432849-E7FD7231-E299-4F76-BCE0-0E5D2D3DC73BQ36632228-E6005AD5-2EBB-4DCF-8A15-9AEDF405C1F2Q36662050-07B92344-B245-42DA-B4B5-A4A37888E838Q37111857-56190372-C470-4D38-8737-C01FC40D25CBQ37310824-4B82E27D-4859-4EBE-8CBD-846E03D5602EQ37449576-AB534C47-CBD4-48E4-A7A1-F47B06D399D2Q37767247-F42E5570-5733-461A-847C-577CF37E4B27Q37871341-29CFE193-C6AC-4E41-B154-7197EA0442DCQ38565049-7680E7AA-987C-4B24-A193-29AE69D9D1B6Q40479039-7341C4FB-7967-48FB-8FC4-9BB2EE159132Q42683242-C1E222F0-A459-4ED1-BF83-F06FAE45FC3EQ50034239-8296F940-36C7-4B16-A6A1-F845120BD101
P2860
Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Cinacalcet hydrochloride (Sens ...... elevated calcium x phosphate.
@en
Cinacalcet hydrochloride
@nl
type
label
Cinacalcet hydrochloride (Sens ...... elevated calcium x phosphate.
@en
Cinacalcet hydrochloride
@nl
prefLabel
Cinacalcet hydrochloride (Sens ...... elevated calcium x phosphate.
@en
Cinacalcet hydrochloride
@nl
P2093
P356
P1476
Cinacalcet hydrochloride (Sens ...... elevated calcium x phosphate.
@en
P2093
CONTROL Investigators
Eric M Chi
Glenn M Chertow
Leonard Stern
Michael Roppolo
Samuel Blumenthal
Stewart Turner
P304
P356
10.2215/CJN.00870805
P577
2006-01-25T00:00:00Z